Social Flash Sale! 25% off the Standard Rates to BPI China and Antibody Engineering China!

Register with code SAVE25 to activate your 25% discount off the standard rates to IBC’s BioProcess International Conference and co-located Antibody Engineering China Conference taking place August 12-13, 2015 in Shanghai, China.

Visit the BPI China Website Here: http://bit.ly/1FsH7tP

Visit the Antibody Engineering China Website Here: http://bit.ly/1F1xYVQ

This 25% discount limited-time offer expires on Tuesday, May 26^th. Register using the below links and use the code: SAVE25

Click Here to Register for BPI China: http://bit.ly/1FsH7tP

Click Here to Register for Antibody Engineering China: http://bit.ly/1F1xYVQ

Don’t miss out on the most comprehensive biologics event in Asia covering the entire spectrum of antibody, protein and biotherapeutic development from discovery and preclinical/clinical to process development and manufacturing.

Hear from the below dynamic keynotes on:

• Multi-specific Biologics
  Robert Friesen, Ph.D., Janssen R&D, LLC (Johnson & Johnson), USA

• Antibody Lead Discovery & Optimization
  Rene Hoet, Ph.D. Bayer Healthcare, Germany

• Analytical Control from Phase I to Post Approval
  Sherry Guo, Ph.D. F. Hoffmann-La Roche Ltd., USA

• And more!

Download the BPI China Brochure Here: http://bit.ly/1PATAUp

Download the Antibody Engineering China Brochure Here: http://bit.ly/1Hzqj8b

Activate your 25% savings now with code SAVE25! Offer expires 5/26

Click Here to Register for BPI China: http://bit.ly/1F1xYVQ

Click Here to Register for Antibody Engineering China: http://bit.ly/1F1xYVQ

Qualifications, rules and regulations:

Offer cannot be applied retroactively to confirmed or pending registrations from today's date and prior. 25% discount cannot be combined with any team discounts or other promotions and/or discount offers. Discount is only valid from May 22– May 26, 2015. All registrations are subject to IBC approval.

Best,

The BPI China and AntiBody Engineering China Teams

@ibcusa

#BPIChina

#AntibodyEngChina

Share this article with your social network, just click below to share now!

Share |

A Look Back at Partnerships in Clinical Trials Asia Pacific!

Last week, we held the First Annual Partnerships in Clinical Trials Asia Pacific. At this meeting, we heard from many of the professionals who work closely with the clinical trails in the region, as well as where the expect to see the region to go within the next few years. See some of the sessions here:

Focus on China

Tailoring Outsourcing Strategies for the Asia-Pacific Region – Functional Insourcing

The Sponsor-Site Relationship: Optimizing the CRO Partnership

How partnering with Japan CROs Can Benefit the Global & Asian Drug Development

Regional Regulatory Briefings – What It Takes to Get Your Regional Clinical Trial Going

Accelerating Patient Recruitment and Retention in Clinical Trials

Share this article with your social network, just click below to share now!

Share |

Biopharma Updates Across the World

This recent post on Biopharmatoday sheds some light on recent biopharma developments from around the world including India, China, Japan, and around the Pacific. Some of the highlights from the article include President Gloria Macapagal-Arroyo from the Philippines signing a new legislation that will transform the nation's top regulatory group. Under the new Act the Bureau of Food and Drugs will replace the Food and Drug Administration. In Europe, Roche became the first multinational pharma company to establish a research and development center in China.

Make sure to take a look at the post for the rest of the updates.

Share this article with your social network, just click below to share now!

Share |